Literature DB >> 9458213

Articular inflammatory manifestations in patients with different forms of leprosy.

W Cossermelli-Messina1, C Festa Neto, W Cossermelli.   

Abstract

OBJECTIVE: To study the articular inflammatory manifestations of leprosy.
METHODS: Sixty patients with leprosy from a public clinic in São Paulo, Brazil, participated in a study regarding their articular manifestations. The diagnosis and classification of leprosy were established by the clinical picture, skin smears, skin biopsy, and delayed hypersensitivity test to Mycobacterium leprae antigens (Mitsuda test). According to the Madrid and Ridley-Jopling classifications, 46 patients had lepromatous leprosy, 7 had borderline leprosy, 4 had tuberculoid leprosy, and 3 had indeterminate leprosy. History, general and articular examinations, and roentgenograms were employed and complemented in several cases by scintigraphic examinations with technetium methylene diphosphonate and computed tomographic studies.
RESULTS: Three patients were excluded from study due to an association with a rheumatic disease. Among the 57 remaining patients, 44 had peripheral arthritis characterized by involvement of small joints (23/44), large joints (4/44), or both (17/44). The mean duration of arthritis was 11 years (range 1 mo to 51 yrs). Arthritis was detected in all subtypes of patients with leprosy. Supplementary radiological evaluation established the extent of inflammation and diagnosis of sacroiliitis. The diagnosis of sacroiliitis, based on the presence of sclerosis, erosions, and narrowing of the cartilage space in the sacroiliac joints, was established in 35 of 55 radiographs. Sacroiliitis varied from grade I to III, according to the Bennet and Wood classification, and was bilateral in most cases (30/35). There was no significant correlation between low back pain and the finding of sacroiliitis.
CONCLUSION: Articular inflammatory manifestations may exist in patients with different forms of leprosy, and can follow a chronic course. In addition, sacroiliitis is a common, previously unrecognized manifestation in patients with leprosy.

Entities:  

Mesh:

Year:  1998        PMID: 9458213

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Leprosy-related joint involvement.

Authors:  H L A Pereira; S L E Ribeiro; S N Pennini; E I Sato
Journal:  Clin Rheumatol       Date:  2008-09-19       Impact factor: 2.980

2.  Remitting seronegative symmetrical synovitis with pitting edema in leprosy.

Authors:  Claudia Andrea Helling; Ana Locursio; Maria Elena Manzur; Maria Leticia Sormani de Fonseca
Journal:  Clin Rheumatol       Date:  2005-09-21       Impact factor: 2.980

3.  Leprosy and rheumatoid arthritis: consequence or association?

Authors:  Celia Coelho Henriques; Begoña Lopéz; Tiago Mestre; Bruno Grima; António Panarra; Nuno Riso
Journal:  BMJ Case Rep       Date:  2012-08-13

4.  Hansen's disease masquerading as rheumatoid arthritis: A case report.

Authors:  Prashant Pant; Oshan Shrestha; Pragyat Singh; Vivek Paudyal; Istiyaque Alam; Prabhat Singh Rajput; Dhan Bahadur Shrestha
Journal:  Clin Case Rep       Date:  2022-05-12

5.  Case Report: Leprosy Osteoarticular Alterations Mimicking Rheumatoid Arthritis.

Authors:  Rachel Bertolani do Espírito Santo; Rachel A Serafim; Jurama Barros Gueiros Bitran; Simon M Collin; Patrícia Deps
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

6.  First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.

Authors:  Haneen Adel Al-Raqum; S S Uppal; Rana Abdul Rahman El Abdalghani; Ibrahim Lasheen
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 3.650

7.  Seronegative Bilateral Symmetrical Inflammatory Polyarthritis: Think Twice Before Starting Immunosuppression.

Authors:  Omar Alsaed; Nawal Hadwan; Izzat Khanjar; Abdul-Wahab Al-Allaf
Journal:  Eur J Case Rep Intern Med       Date:  2018-08-28

Review 8.  Leprosy in a rheumatology setting: a challenging mimic to expose.

Authors:  Sheetal Salvi; Arvind Chopra
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.